Insider Transactions in Q4 2020 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,617
-2.15%
|
$175,191
$23.09 P/Share
|
|
Dec 31
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,620
-1.07%
|
$60,260
$23.09 P/Share
|
|
Dec 31
2020
|
Hung Do Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,340
-1.3%
|
$122,820
$23.09 P/Share
|
|
Dec 31
2020
|
Ellen Rosenberg Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,751
-2.43%
|
$109,273
$23.09 P/Share
|
|
Dec 31
2020
|
John F Crowley Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
16,287
-1.98%
|
$374,601
$23.09 P/Share
|
|
Dec 21
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.01%
|
$120,000
$24.09 P/Share
|
|
Dec 21
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.97%
|
$10,000
$2.94 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,760
-1.32%
|
$109,480
$23.86 P/Share
|
|
Dec 15
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,828
+2.86%
|
$104,140
$5.42 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,156
-1.67%
|
$95,588
$23.86 P/Share
|
|
Dec 15
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,321
+3.08%
|
$90,963
$3.33 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
22,000
-2.6%
|
$506,000
$23.91 P/Share
|
|
Dec 15
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+2.54%
|
$132,000
$6.45 P/Share
|
|
Dec 14
2020
|
Hung Do Chief Science Officer |
SELL
Open market or private sale
|
Direct |
111,125
-21.34%
|
$2,555,875
$23.88 P/Share
|
|
Dec 01
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.75%
|
$34,500
$23.5 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,783
-6.82%
|
$545,226
$22.77 P/Share
|
|
Dec 01
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,783
+6.38%
|
$49,566
$2.52 P/Share
|
|
Dec 01
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
7,500
-0.9%
|
$165,000
$22.77 P/Share
|
|
Dec 01
2020
|
Michael Aaron Kelly |
BUY
Grant, award, or other acquisition
|
Direct |
8,837
+50.0%
|
-
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,931
-25.71%
|
$118,620
$20.0 P/Share
|
|
Nov 04
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,931
+10.85%
|
$71,172
$12.46 P/Share
|
|
Nov 02
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,782
-6.82%
|
$421,294
$17.87 P/Share
|
|
Nov 02
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,782
+6.38%
|
$49,564
$2.52 P/Share
|
|
Nov 02
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
33,875
-3.92%
|
$575,875
$17.87 P/Share
|
|
Nov 02
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
23,975
+2.7%
|
$119,875
$5.96 P/Share
|
|
Nov 02
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+3.9%
|
$27,000
$18.01 P/Share
|
|
Oct 09
2020
|
David Michael Clark Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,510
-3.76%
|
$82,650
$15.12 P/Share
|
|
Oct 09
2020
|
Hung Do Chief Science Officer |
SELL
Open market or private sale
|
Direct |
193,700
-27.11%
|
$2,905,500
$15.03 P/Share
|
|
Oct 09
2020
|
Hung Do Chief Science Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
193,700
+9.06%
|
$1,743,300
$9.97 P/Share
|
|
Oct 02
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+4.8%
|
$22,000
$2.45 P/Share
|
|
Oct 01
2020
|
Daphne Quimi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.36%
|
$70,000
$14.02 P/Share
|
|
Oct 01
2020
|
Daphne Quimi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.3%
|
$10,000
$2.94 P/Share
|
|
Oct 01
2020
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
29,900
-3.43%
|
$418,600
$14.02 P/Share
|
|
Oct 01
2020
|
John F Crowley Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+2.25%
|
$100,000
$5.96 P/Share
|
|
Oct 01
2020
|
Burke W Whitman |
BUY
Open market or private purchase
|
Direct |
1,500
+4.06%
|
$21,000
$14.28 P/Share
|